Physician profile
Haim Cohen
NPI 1164405809
$11,985.97
in general payments reported to CMS, 2019-2025
27 companies · $772 in 2025
The $772 reported for 2025 was more than what 81% of Sports Medicine (Podiatrist) providers received nationally (typical 2025 total: $307).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,298 · 2020: $1,374 · 2021: $3,833 · 2022: $2,890 · 2023: $897 · 2024: $922 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,591.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legacy Ortho LLC | $3,649.64 | 2021-2025 | |
| Kerecis Limited | $1,765.49 | 2020-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Smith+Nephew, INC. | $1,383.77 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix |
| Organogenesis INC. | $1,187.86 | 2019-2025 | Puraply, Apligraf |
| Misonix INC | $817.65 | 2019-2021 | |
| Stryker Corporation | $685.32 | 2021-2025 | Viaflow, Prophecy, Citrefix |
| Cdc Medical LLC | $632.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $288.30 | 2020-2025 | Nuzyra |
| Bioventus LLC | $277.17 | 2022-2024 | Theragenesis Bilayer Wound Matrix, Exogen Ultrasound Bone Healing System |
| Amgen INC. | $255.45 | 2024-2025 | Krystexxa |
| Pacira Therapeutics, INC. | $153.15 | 2019-2021 | |
| Boston Scientific Corporation | $133.71 | 2024 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $127.86 | 2021-2022 | |
| Osiris Therapeutics INC. | $124.85 | 2019 | |
| Checkpoint Surgical, INC | $110.15 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $71.01 | 2020-2021 | |
| Solventum Corporation | $70.15 | 2024-2025 | V.A.C.Ulta, Activ.A.C., Prevena |
| Mimedx Group, INC. | $55.26 | 2024-2025 | |
| Geistlich Pharma, North America, INC. | $42.21 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $28.95 | 2021 | |
| Kci USA, INC. | $26.35 | 2020 | |
| Triad Life Sciences INC. | $22.92 | 2021 | |
| Medline Industries Lp | $18.66 | 2021 | |
| Averitas Pharma INC. | $16.86 | 2024 | Qutenza |
| Heron Therapeutics, INC. | $15.95 | 2022 | |
| Wright Medical Technology, INC. | $13.56 | 2019 | |
| Integra Lifesciences Corporation | $11.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haim Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.